Spontaneous activity of serotonergic neurons of the dorsal raphe nucleus (DRN) regulates mood and motivational state. Potentiation of serotonergic function is one of the therapeutic strategies for treatment of various psychiatric disorders, such as major depression, panic disorder and obsessivecompulsive disorder. However, the control mechanisms of the serotonergic firing activity are still unknown. In this study, we examined the control mechanisms for serotonergic spontaneous activity and effects of chronic antidepressant administration on these mechanisms by using modified ex vivo electrophysiological recording methods. Serotonergic neurons remained firing even in the absence of glutamatergic and GABAergic ionotropic inputs, while blockade of L-type voltage dependent Ca 2+ channels (VDCCs) in serotonergic neurons decreased spontaneous firing activity. L-type VDCCs in serotonergic neurons received gamma-aminobutyric acid B (GABA B ) receptor-mediated inhibition, which maintained serotonergic slow spontaneous firing activity. Chronic administration of an antidepressant, citalopram, disinhibited the serotonergic spontaneous firing activity by weakening the GABA B receptor-mediated inhibition of L-type VDCCs in serotonergic neurons. Our results provide a new mechanism underlying the spontaneous serotonergic activity and new insights into the mechanism of action of antidepressants.
previous study suggests the existence of intrinsic pacemaker mechanisms in serotonergic neurons 8 . Until now, this contradiction between in vivo and ex vivo studies was not resolved.
Like most neurons, serotonergic neurons receive local GABAergic inhibitory inputs 9 . Recently, we investigated the local feedback circuit between DRN serotonergic neurons and GABAergic interneurons and found that continuous GABAergic inhibition maintains serotonergic activity 10 . GABA A receptor-mediated ionotropic inputs are well-studied, while several lines of evidence suggest that postsynaptic GABA B receptors may contribute to the modulation of serotonergic neurons 4, 11 . Furthermore, chronic stress increases GABAergic neuronal activity and GABA B receptor expression in the DRN 12, 13 . These observations indicate the possibility that GABA B receptor-mediated signaling contributes to the modulation of the baseline activity of serotonergic neurons, while little is known about its molecular mechanisms of GABA B receptor-mediated inhibition of serotonergic neurons.
Most of the clinically-used drugs for psychiatric disorders such as selective serotonin reuptake inhibitors (SSRIs) modulate the serotonergic function of the brain 14 , while the precise mechanisms of such serotonergic drugs remain to be elucidated. Antidepressants have a delayed onset of action, suggesting that chronic antidepressant treatment-induced cellular and synaptic changes are necessary for the therapeutic action 15, 16 . Consistent with these reports, we previously showed that chronic treatment with antidepressants enhances serotonin release in vitro 17, 18 . These findings suggest the possibility that chronic treatment with antidepressant potentiates serotonergic activity.
In the present study, by using modified ex vivo electrophysiological recording method, we could record serotonergic spontaneous firing activity even without any stimulations. This spontaneous firing activity was mainly regulated by L-type voltage-dependent Ca 2+ current, which was continuously inhibited by GABA B receptor-mediated signaling. Moreover, chronic administration of an antidepressant disinhibited the serotonergic spontaneous firing activity by weakening the GABA B receptor-mediated continuous inhibition. These results offer a new mechanism for the GABAergic inhibition of DRN serotonergic neurons, which was responsive to chronic antidepressant treatment.
Results

DRN serotonergic neurons spontaneously generate action potentials in ex vivo electrophysiological recordings.
To examine control mechanisms for DRN serotonergic activity, we modified the recording method, which enables recording serotonergic spontaneous firing activity. While most of previous researches pointed out that serotonergic neurons are silent in ex vivo recordings 2, 6 , recent study suggests that part of serotonergic neurons (~50%) showed spontaneous firing activity in "high quality" brain slices 7 . To increase spontaneously active serotonergic neurons, we prepared coronal brain slices with strictly controlled knife speed and vibration (see Methods) to avoid pressure-induced neuronal damage. Additionally, we used NMDG-based cutting solution, which are suitable for slicing adult brains 19 . By these modifications, we achieved recording spontaneous firing activity from more than 75% of DRN serotonergic neurons, which expressed Tph2 mRNA ( Fig. 1a ,e; Supplementary Fig. S1 ). Similar to previous reports 2 , serotonergic neurons showed wide action potential (AP) and large afterhyperpolarization (AHP) amplitude ( Fig. 1b,e ). To examine AP threshold and resting membrane potential (RMP) in spontaneously active serotonergic neurons, we used phase plane plot and voltage histogram, respectively 20 (Fig. 1c,d ). In our methods, most of firing characters were essentially similar to those reported previously 7,21 , while slight depolarization of RMP (−48.1 ± 1.1 mV) and low AP threshold (−38.9 ± 1.4 mV) were observed compared to the previous data (RMP; −56 ± 3.6 mV, AP threshold; −28 ± 1.1 mV) 22 (Fig. 1e ).
We next confirmed whether the spontaneous firing activity of serotonergic neurons depends on extrinsic synaptic inputs or intrinsic activity, we examined the contribution of major ionotropic inputs and noradrenergic α 1 receptor 2,4 ( Fig. 1f ). Bath application of glutamate and GABA A receptor antagonists (20 μM 6,7-dinitroquinoxaline -2,3-(1 H, 4 H)-dione [DNQX], 50 μM DL-(-)-2-amino-5-phosphonopentanoic acid [APV], and 20 μM bicuculline) slightly decreased but did not eliminate spontaneous firing activity of serotonergic neurons ( Fig. 1g ,i). Similarly, α 1 receptor antagonist (1 μM prazosin) failed to abolish the spontaneous activity ( Fig. 1h ,i), suggesting that serotonergic spontaneous activity shown here mainly depended on intrinsic activity of serotonergic neurons.
L-type voltage-dependent calcium current is responsible for the spontaneous firing activity of DRN serotonergic neurons.
In several types of spontaneously active neurons, such as dopaminergic neurons, the major factors for generating firing activity are T-type voltage-dependent calcium channels (VDCCs) and hyperpolarization-activated cyclic nucleotide-gated (HCN) channels 23, 24 . Different from other pacemaker neurons, low-voltage activated (LVA) current and negative current injection-mediated voltage sag, which reflects the function of T-type VDCCs and HCN channels respectively, were subtle in serotonergic neurons ( Supplementary  Fig. S2b ,c). Consistent with these observations, the blocking of T-type VDCCs (50 μM NiCl 2 ) or HCN channels (20 μM ZD7288) did not decrease the serotonergic firing activity ( Supplementary Fig. S2d ).
Recently, L-type VDCCs were recognized as machinery for generating spontaneous firing activity 25 . We next examined the involvement of L-type VDCCs in spontaneous firing activity. Blocking of L-type VDCCs with 10 μM nifedipine significantly decreased the spontaneous firing rate of serotonergic neurons ( Supplementary  Fig. S2a,d ). On the contrary, bath application of an L-type VDCC activator, 1 μM (S)-(−)-Bay K 8644, significantly increased the spontaneous firing rate ( Fig. 2a,b ). As L-type VDCCs are widely expressed in the brain, we examined whether L-type VDCCs on serotonergic neurons or other neurons are critical for the spontaneous serotonergic activity. To test this issue, we performed intracellular application of a membrane-impermeable L-type VDCC blocker 0.5 mM D890 via a patch pipette, where L-type VDCCs are active in cell attached recordings and blocked after establishing whole-cell recordings. Intracellular application of D890 significantly decreased the spontaneous firing in whole-cell recordings compared to the basal firing rate in cell-attached recordings of the same neurons ( Fig. 2c,d) . We further assessed the effects of GABA B receptor-mediated inhibition of spontaneous firing activity. To exclude the involvement of ionotropic inputs and presynaptic GABA B receptor-mediated change in serotonin release, we recorded the firing activity in the presence of antagonists of AMPA, NMDA, and GABA A receptors and 5-hydroxytryptamine 1 (5-HT 1 ) autoreceptors (20 μM DNQX, 50 μM APV, 20 μM bicuculline, 0.1 μM WAY100635, and 1 μM GR127935, termed as "antagonist mix"). Application of the antagonist mix did not affect the spontaneous firing rate of serotonergic neurons ( Supplementary Fig. S3 ). In the presence of the antagonist mix, CGP52432 significantly increased the firing rate of serotonergic neurons. The increasing effect of CGP52432 was blocked by the intracellular application of KT5720 or D890 ( Fig. 3c,d ). Each drug application had no significant effect on electrophysiological characteristics, except for L-type VDCC blocker-induced elongation of AP duration 25 ( Supplementary Table S1 ). These results indicate that GABA B receptor-mediated inhibition reduces the serotonergic spontaneous firing activity by inhibiting L-type VDCC current.
Chronic antidepressant increases spontaneous firing activity of DRN serotonergic neurons. It
is widely accepted that potentiation of serotonergic system is important for the therapeutic activity of antidepressants [15] [16] [17] [18] , whereas the effects and mechanisms of action of antidepressants on the activity of serotonergic neurons are unclear. We thus examined whether chronic administration of SSRIs activates DRN serotonergic activity. Mice were treated with an SSRI, citalopram (24 mg/kg/day, in drinking water) for 28 days, and ex vivo whole-cell recordings were performed (Fig. 4a ). Under normal ACSF condition, the spontaneous activity of DRN serotonergic neurons was significantly increased by chronic treatment with citalopram compared to the drug-naïve (water-drinking) group (Fig. 4b ). To further assess whether the citalopram-induced increase in the spontaneous firing rate depends on the changes in synaptic inputs, autoinhibition, or serotonergic intrinsic activity, we examined the firing activity of DRN serotonergic neurons in the presence of the antagonist mix. Even in the presence of antagonist mix, the spontaneous firing activity of serotonergic neurons in the citalopram-treated group was significantly higher than that in the drug-naïve group (Fig. 4c ).
As shown in Fig. 2d , intracellular application of D890 decreased spontaneous firing activity in both the drug-naïve and citalopram-treated groups, and in this condition, chronic citalopram-induced increase in spontaneous firing rate was not observed (Fig. 4d) . Similarly, in the presence of the antagonist mix, bath application of nifedipine (10 μM) also blocked chronic citalopram-induced increase in spontaneous firing activity ( Supplementary Fig. S7a ).
Although one of the postulated mechanisms of action of SSRI on serotonergic neurons was decreasing 5-HT 1A receptor-mediated autoinhibition 15, 30 , SSRI also decreases GABA B receptor-mediated signaling 11 . Based on this observation, we hypothesized that chronic administration of citalopram disinhibits serotonergic neurons by decreasing the GABA B receptor-mediated inhibition. Consistent with the previous report 11 , GABA B receptor agonist (1 mM baclofen)-induced outward current was decreased in the citalopram-treated mice, indicating decreased GABA B receptor function in serotonergic neurons ( Supplementary Fig. S4 ). As observed in Fig. 3d , blocking GABA B receptors increased the spontaneous activity of serotonergic neurons in the drug-naïve mice. On the other hand, blocking of GABA B receptors failed to increase firing rate in the citalopram-treated group, resulting in no difference between the drug-naïve and citalopram-treated groups (Fig. 4e ). Furthermore, the intracellular application of KT5720 prevents chronic citalopram-induced increase in spontaneous activity, supporting the hypothesis that chronic citalopram activates serotonergic neurons through decreasing GABA B receptor-signaling and following increase in PKA activity (Fig. 4f ).
Evidence suggests that GABA B receptor-mediated activation of G protein-coupled inwardly-rectifying K + (GIRK) channels inhibits serotonergic neurons through hyperpolarization of the RMP 31 . However, there was no difference in pseudo RMP between the drug-naïve and citalopram-treated groups ( Supplementary Table S2 ), indicating that chronic citalopram-induced activation of serotonergic neurons was not due to hyperpolarization of RMP. In addition, there was no positive correlation between spontaneous firing rate and pseudo RMP in "normal ACSF", "Antagonist mix" and "Antagonist + CGP" recording conditions ( Supplementary Fig. S5a,b,d) . On the contrary, significant positive correlation between spontaneous firing rate and pseudo RMP was observed in "D890 in pipette" and "KT5720 in pipette" conditions, where activity of L-type VDCCs were low ( Supplementary  Fig. S5c,e ). These results suggest that the value of RMP had little effect on spontaneous firing activity, at least when L-type VDCCs are normally active.
Chronic antidepressant activates L-type VDCCs in DRN serotonergic neurons.
We next examined the effects of chronic administration of citalopram in L-type VDCC current in serotonergic neurons (Fig. 5a ). Voltage-clamp recordings showed that high voltage activated (HVA) current was significantly increased by chronic citalopram administration, while low-voltage activated current was not affected (Fig. 5b , Supplementary  Fig. S6 ). The citalopram-induced increase in HVA current was abolished by the intracellular application of D890 or bath application of nifedipine ( Fig. 5c, Supplementary Fig. S7b ), indicating that chronic citalopram increased L-type VDCC current. Similar to spontaneous activity, blocking GABA B receptors also increased VDCC current in the drug-naïve group but not in the citalopram-treated group, resulting in no difference between two groups (Fig. 5d ). In the presence of nifedipine, CGP52432 did not increase HVA current in both groups, suggesting that the effect of CGP52432 in Fig. 5d was not due to the increase in other types of HVA VDCC current ( Supplementary Fig. S7b ). Although 5-HT 1 autoreceptors are also G i/o -coupled G protein-coupled receptors, bath application of 5-HT 1 receptor antagonists had no effect on chronic citalopram-induced increase in VDCC current (Fig. 5e ).
Moreover, consistent with current clamp data, intracellular KT5720 also diminished the increasing effect of citalopram on HVA current (Fig. 5f ). However, intracellular application of gallein (20 μM)-induced inhibition of G βγ signaling, which is another downstream signaling by GABA B receptors, did not affect the effect of chronic citalopram on VDCC current (Fig. 5g) , indicating that disinhibition of PKA via decreasing GABA B receptor signaling might play a critical part in SSRI-induced increase in VDCC current (Fig. 5h ).
Discussion
In this study, we determined the control mechanisms for serotonergic spontaneous firing activity. Furthermore, we found that chronic antidepressant treatment increased DRN serotonergic spontaneous activity by enhancing the spontaneous firing activity through a novel mechanism that weakens the GABA B receptor-mediated inhibition of L-type VDCCs (Fig. 5h ). In the central nervous system, several types of neurons such as the midbrain dopaminergic neurons show spontaneous firing activity 26 . By using modified ex vivo recordings, we found that the vast majority of DRN serotonergic neurons were spontaneously active. Our data also exhibited the capability of serotonergic neurons to generate spontaneous firing activity without excitatory glutamatergic inputs or noradrenergic inputs, which are thought to be the major driving force for the firing activity of serotonergic neurons.
It is widely accepted that noradrenergic signaling on serotonergic neurons maintain serotonergic tonic activity and in ex vivo slices weak α 1 receptor signaling causes low serotonergic spontaneous activity 2, 32 . In accordance, effect of α 1 antagonist on spontaneous firing activity was slight in our recording method, suggesting that spontaneous activity shown here was not due to the increase in noradrenergic inputs. On the other hand, the significant contribution of α 1 receptor signaling on in vivo serotonergic activity was well established 33 . Further study will be needed to reveal the involvement of intrinsic mechanisms shown in present study on serotonergic activity control in vivo.
Although T-type VDCCs and HCN channels are the well-known molecular basis for generating spontaneous firing activity 24 , growing evidence suggests that L-type VDCCs, especially Cav1.3, which has a low voltage threshold 34 (−55 mV), also contribute to maintaining the spontaneous firing activity 25 . In Cav1.3 knockout mice, the spontaneous firing activity of ventral tegmental dopaminergic neurons is lower than that in wild-type mice, whereas the activation of L-type VDCC increases the burst firing of dopaminergic neurons 35 . Consistent with these reports, the present results showed that activation of L-type VDCC also increased DRN serotonergic neuronal activity. Considering that pseudo RMPs of most of spontaneously active serotonergic neurons in this report were higher than voltage threshold of Cav1.3, present results strongly indicate the involvement of L-type VDCCs on generation of spontaneous firing activity.
For generating APs, depolarizing Ca 2+ current through L-type VDCCs at subthreshold membrane potential plays an essential role 36 , while Ca 2+ influx-driven subsequent signals, such as activation of Ca 2+ -activated K + channels, also controls cell excitability. Ca 2+ -activated SK and BK channels are functionally coupled with L-type VDCCs and activation of these channels contributes to the generation of AHP 25, 37 . SK channel-induced AHP are known to slow down firing activity and blockade of SK channels increases burst-like activity in serotonergic neurons 38 . On the contrary, BK current-induced repolarization are required for spontaneous firing activity and L-type VDCC activator-induced increase in firing rate 25, 39 . While present data suggested that increasing depolarizing current through L-type VDCCs accelerate AP generation, subsequent signalings such as Ca 2+ -activated K + channels-induced repolarization might be involved in the maintenance of increased tonic firing activity.
It is well-known that the local GABAergic inhibition decreases serotonergic activity 4, 10 . Besides ionotropic GABA A receptors, metabotropic GABA B receptors are also expressed in serotonergic neurons 31 . Whereas both serotonergic and GABAergic neurons in the DRN express GABA B receptors, our analysis with intracellular drug application suggest that the activation of postsynaptic GABA B receptors plays an essential role in the inhibition of serotonergic neurons. While GABA B receptor agonist-induced activation of GIRK channels and subsequent membrane hyperpolarization are well-studied 11, 31, 40 , GABA B antagonist-induced depolarization was subtle in present study, suggesting that inactivation of GIRK channels had little effects on GABA B antagonist-induced activation of serotonergic firing activity. However, additional researches will be required to investigate the downstream signalings of GABA B receptors and how those signalings control serotonergic activity.
In present study, we showed that inhibition of postsynaptic GABA B receptors in serotonergic neurons increased serotonergic activity. By contrast, previous evidences indicate that intra-DRN application of GABA B agonist increases serotonin and glutamate release by stimulation of presynaptic GABA B receptors [41] [42] [43] . Additionally, Milnar et al. have shown that co-treatment of GABA A and GABA B antagonists had no effect on the firing rate of phenylephrine-treated serotonergic neurons 44 . One of the reasons for this apparent discrepancy between previous reports and our results might be difference in recording condition. In the present experiments with GABA B antagonist, GABAergic and glutamatergic ionotropic inputs were also blocked, where these blockers might mask changes in glutamate and GABA release through inhibition of presynaptic GABA B receptors. Consequently, the effects of postsynaptic GABA B receptor-antagonism might become highlighted. Further assessment of selective inhibition of GABA B receptors on serotonergic neurons would be needed to elucidate GABA B receptor-mediated control of serotonergic intrinsic activity.
GABA B receptors interact with a variety of channels and modulate their function 45 . The interaction between GABA B receptors and P/Q-type VDCCs is widely accepted as the mechanism of action for GABA B receptor-mediated inhibition of neurotransmitter release 29 . Whereas, there is no consensus on whether and how GABA B receptors modulate L-type VDCCs because the effects of GABA B receptor activation on L-type VDCCs varies with maturation state of cells 46, 47 . Evidence suggests that GABA B receptors couple to G q proteins and activate L-type VDCC through PKC signaling during neonatal development 48 . In this study, we used adult mice where GABA B receptors might mainly couple to G i proteins. Considering that PKA-mediated phosphorylation is one of the activation pathway of L-type VDCC 49 , present results indicate that GABA B antagonist activates L-type VDCCs through disinhibiting PKA.
Whereas an antidepressant-induced increase in synaptic serotonin level and subsequent stimulation of postsynaptic serotonin receptors in the projection areas plays an important role in antidepressant effects 50, 51 , accumulating evidence indicates that the altered DRN serotonergic activity contributes to the pathology and treatment of mental disorders [3] [4] [5] . Under stress conditions, the activity of serotonergic neurons is decreased 3, 4 , and thus, chronic treatment with an antidepressant might potentiate its therapeutic effects by disinhibiting serotonergic activity.
As widely accepted, acute SSRI administration decreases activity of serotonergic neurons by increasing local serotonin levels, while continuous increase in serotonin level desensitizes 5-HT 1A autoreceptors and increases serotonin release 15, 52 . Recent evidence indicates that dendritic serotonin release in DRN is mainly mediated by L-type VDCCs 53 , suggesting that chronic SSRI induced activation of L-type VDCC increases local serotonin release and might also facilitates disinhibition of 5-HT 1A autoreceptors. While chronic SSRI-induced activation SCientifiC REPORTS | 7: 13609 | DOI:10.1038/s41598-017-13599-3 of serotonergic neurons were still observed in the presence of antagonist mix, that contains a 5-HT 1A receptor antagonist, it is possible that chronic SSRI-induced activation of L-type VDCC further activate serotonergic neurons via disinhibiting autoreceptors. Additional research is required to identify the interaction between chronic SSRI-induced activation of L-type VDCCs and desensitization of autoreceptors.
The contribution of GABA B receptors to pathogenesis and treatment for mental disorders has long been discussed. Systemic administration of GABA B receptor antagonist shows serotonin-dependent antidepressant-like effect 54, 55 . Furthermore, mice lacking GABA B1b , which preferentially exists as a postsynaptic GABA B receptor, acquire stress resilience 12, 56 . Consistent with a previous study 11 , our findings suggest that down regulation of postsynaptic GABA B signaling in serotonergic neurons is essential for the antidepressant effect of SSRIs. On the contrary, upregulation of GABA B receptor-mediated signaling produces an antidepressant-like effect in the lateral habenula and hippocampus 39, 57 . These discrepancies indicate that region-specific modulation of GABA B signaling is critical for therapeutic effects. In this situation, our finding of the GABA B receptor-L-type VDCC signaling-mediated modulation of serotonergic function provides a novel strategy for the treatment of psychiatric disorders.
Present results suggest that chronic inhibition of serotonin transporter (SERT) decreases GABA B receptor signaling in serotonergic neurons. Unlike 5-HT 1A receptors, GABA B receptors do not internalize due to prolonged agonist exposure, and phosphorylation/dephosphorylation balance of GABA B receptors determines their membrane expression and complex formation 58, 59 . Evidence suggests that the chronic but not acute administration of SSRI decreases the expression of several protein kinases 60, 61 . In this context, one of the possible mechanisms that explain the missing link between SERT inhibition and decrease in GABA B receptor signaling is that chronic treatment with SSRI might reduce phosphorylation of GABA B receptors by decreasing kinase expression. Further research will be needed to determine chronic SERT inhibition-induced signalings in serotonergic neurons.
In conclusion, the current ex vivo electrophysiological investigations indicated that DRN serotonergic neurons possess spontaneous firing activity, in which L-type VDCC is a key modulator. This spontaneous activity received tonic inhibition through GABA B receptor-mediated inhibition of L-type VDCCs, and chronic administration of SSRI weakened this inhibition. Our findings provide a new mechanism for the regulation of serotonergic activity and raise the possibility that postsynaptic GABA B receptor-mediated inhibition of L-type VDCCs in serotonergic neurons might be a promising target for the treatment of psychiatric disorders.
Methods
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Electrophysiological recordings. Electrophysiological recordings were performed as previously described 10 with several modifications. Electrophysiological recordings were performed with an EPC9 amplifier (HEKA, Pfalz, Germany), and the data were recorded using Patchmaster software (HEKA). The resistance of the electrodes was 3-6 MΩ when filled with the internal solution (composition in mM; 140 K-gluconate, 5 KCl, 10 HEPES, 2 Na-ATP, 2 MgCl 2 , and 0.2 EGTA, pH 7.3 adjusted with KOH for current clamp recordings, and 120 CsMeSO 4 , 15 CsCl, 8 NaCl, 10 HEPES, 2 Na-ATP, 0.3 Na-GTP, 0.2 EGTA, 10 TEA-Cl, and 5 QX-314, pH 7.3 adjusted with CsOH for voltage clamp recordings). Individual neurons were visualized with a microscope equipped with a 40 × water-immersion objective lens (Carl Zeiss, Jena, Germany) and a CCD camera. The series resistance was compensated by 70% and maintained within 20 MΩ.
The spontaneous firing was examined in cell-attached or whole-cell current-clamp recordings. Cell-attached recordings were performed at a holding potential of 0 mV. In whole-cell current-clamp recordings, the current was held at 0 pA. For comparing the spontaneous activity between different neurons, spontaneous firing activity was recorded for 30 s after stabilization. To examine the change in spontaneous firing within a neuron, the average firing rate in the first 30 s was considered as the basal firing rate. VDCC current was recorded under a voltage-clamp condition in the presence of DNQX (20 μM), APV (50 μM), bicuculline (20 μM), and tetrodotoxin (1 μM), and was generated by depolarizing voltage steps from −110 mV to −40 mV or −10 mV. Membrane potential between recordings was held at −70 mV. Baclofen-induced current was recorded in the presence of DNQX (20 μM), APV (50 μM), and bicuculline (20 μM), and the holding potential was set at −50 mV.
Single-cell reverse transcription-polymerase chain reaction (RT-PCR).
Single-cell RT-PCR was performed as previously described 10 . After the whole-cell recording, the contents of the cell were aspirated into the recording pipette and harvested in a sampling tube. The collected samples were reverse-transcribed using a ReverTra Ace RT kit (TOYOBO, Tokyo, Japan) and amplified with Blend Taq (TOYOBO, Tokyo, Japan). The oligonucleotide primers used were 5′-TAGGCTTAGCGTCTCTGGGA-3′ and 5′-AAGGCCGAACTCGATTGTGA-3′ for Tph2; 5′-GGCCTGAAGATCTGTGGCTT-3′ and 5′-CAGAACCTTGGTGGAGCGAT-3′) for Gad1; 5′-ATGCAGAGCTGCAACCAGAT-3′ and 5′-GCCTCAAACCCAGTAGTCCC-3′ for Gad2; 5′-CCGCTGATCCTTCCCGATAC-3′ and 5′-CGACGTTGGCTGTGAACTTG-3′ for Eno2 as a neuronal marker. PCR products were analyzed using agarose gel electrophoresis. Only when Tph2 mRNA expression was detected, the data was used for analysis ( Fig. 1a ).
Statistics.
All data are presented as the mean ± standard error of mean (S.E.M). Statistical analysis was performed by GraphPad Prism 5 (GraphPad, San Diego, CA, USA). Differences with P < 0.05 were considered significant. The differences between two groups were compared by two-tailed Student's t-test. When comparing differences within the cell, two-tailed paired t-test was used for analysis. The differences between more than three groups were compared by one-way analysis of variance (ANOVA) with post hoc Tukey's Multiple Comparison Test. When examining the time-course, two-way ANOVA for repeated measures was used for analysis. For correlation analysis, Pearson correlation coefficients were used.
